Vitamin B12–Derived Therapy Penetrates Brain Barrier to Target Glioblastoma

1 min read
Source: ScienceDaily
Vitamin B12–Derived Therapy Penetrates Brain Barrier to Target Glioblastoma
Photo: ScienceDaily
TL;DR

Researchers report that a vitamin B12–based compound, nitrosylcobalamin (NO-Cbl), can cross the blood-brain barrier, selectively accumulate in glioblastoma tumors, and deliver nitric oxide to cancer cells in preclinical models; it also shows synergistic activity with temozolomide (and TRAIL) to enhance tumor suppression, offering a promising but early approach that requires further validation before clinical use.

Share this article

Want the full story? Read the original reporting

Read on ScienceDaily